Enzo Biochem - 40 Year Stock Price History | ENZ

Historical daily share price chart and data for Enzo Biochem since 1980 adjusted for splits. The latest closing stock price for Enzo Biochem as of October 28, 2020 is 1.86.
  • The all-time high Enzo Biochem stock closing price was 122.00 on January 21, 2000.
  • The Enzo Biochem 52-week high stock price is 4.85, which is 160.8% above the current share price.
  • The Enzo Biochem 52-week low stock price is 1.56, which is 16.1% below the current share price.
  • The average Enzo Biochem stock price for the last 52 weeks is 2.50.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Enzo Biochem Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 2.4375 2.7600 3.8700 1.8200 1.8600 -29.28%
2019 3.3306 2.8000 4.3100 2.5400 2.6300 -5.40%
2018 5.2278 8.2500 8.3600 2.4600 2.7800 -65.89%
2017 9.2622 7.1400 11.7900 6.4000 8.1500 17.44%
2016 5.5990 4.6900 7.4800 4.0600 6.9400 54.22%
2015 3.3382 4.4500 4.9500 2.4300 4.5000 1.35%
2014 4.4767 2.9200 6.0800 2.6900 4.4400 52.05%
2013 2.4717 2.7500 3.1000 1.9400 2.9200 8.15%
2012 2.2276 2.3700 3.0500 1.4600 2.7000 20.54%
2011 3.5622 5.5000 5.7900 1.9900 2.2400 -57.58%
2010 4.8886 5.6700 6.6700 3.3700 5.2800 -1.86%
2009 5.0182 5.1000 7.6600 2.9000 5.3800 10.02%
2008 9.3999 12.9800 14.8300 3.5000 4.8900 -61.62%
2007 14.3258 14.5700 18.6500 10.0500 12.7400 -10.72%
2006 12.8201 12.5500 16.0000 9.3000 14.2700 14.90%
2005 15.4169 19.3000 19.3000 12.4200 12.4200 -36.21%
2004 16.2483 17.9500 20.4500 11.7100 19.4700 8.71%
2003 17.7666 14.6000 28.4300 11.5200 17.9100 27.93%
2002 16.6054 24.5500 25.7200 11.6500 14.0000 -40.43%
2001 22.9783 21.8100 34.9800 13.9500 23.5000 -5.55%
2000 53.9979 44.0000 122.0000 20.4400 24.8800 -45.91%
1999 17.7067 10.3800 46.8800 8.1250 46.0000 346.17%
1998 12.2603 14.6300 16.2500 6.5000 10.3100 -29.53%
1997 15.9713 18.5000 20.6300 13.0000 14.6300 -19.26%
1996 17.3435 19.7500 21.1300 14.2500 18.1200 -5.87%
1995 14.2192 11.3800 23.7500 9.6250 19.2500 72.96%
1994 12.4075 16.0000 19.3800 7.7500 11.1300 -29.91%
1993 10.8082 7.7500 19.8800 6.5000 15.8800 115.32%
1992 5.0900 3.3700 7.5000 3.2500 7.3750 96.67%
1991 1.6484 1.8800 7.8800 0.5000 3.7500 76.06%
1990 3.0223 3.8700 4.5000 1.7500 2.1300 -41.16%
1989 3.6294 3.1300 4.8700 2.6300 3.6200 11.38%
1988 3.9506 4.0000 4.8700 2.5000 3.2500 -13.33%
1987 8.4392 8.7500 12.1200 3.2500 3.7500 -57.14%
1986 12.7321 12.1200 18.7500 8.3800 8.7500 -29.26%
1985 14.1660 15.2500 21.0000 10.3700 12.3700 -17.53%
1984 16.3823 25.6200 26.2500 12.2500 15.0000 -39.69%
1983 24.7116 16.2467 33.5000 16.2467 24.8700 40.77%
1982 10.3396 10.5000 17.6667 5.5000 17.6667 66.98%
1981 9.2933 3.6233 15.0800 3.4567 10.5800 192.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.095B $0.076B
Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo Diagnostics, Inc., Enzo Therapeutics, Inc., and Enzo Clinical Labs, Inc. The primary focus of the company's research is the development of products based on two technology platforms -- genetic modulation and immune modulation.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $135.015B 10.40
Amgen (AMGN) United States $131.717B 14.31
CSL (CSLLY) Australia $95.198B 0.00
Gilead Sciences (GILD) United States $75.173B 10.82
Regeneron Pharmaceuticals (REGN) United States $62.318B 23.83
Vertex Pharmaceuticals (VRTX) United States $53.956B 30.11
Illumina (ILMN) United States $46.583B 54.17
Biogen (BIIB) United States $39.511B 7.02
Seattle Genetics (SGEN) United States $34.074B 0.00
Moderna (MRNA) United States $27.716B 0.00
BeiGene (BGNE) Cayman Islands $27.306B 0.00
Alexion Pharmaceuticals (ALXN) United States $26.467B 11.03
Genmab (GMAB) Denmark $22.905B 14.45
Genmab (GNMSF) Denmark $21.264B 4.90
Incyte (INCY) United States $19.779B 0.00
BioNTech SE (BNTX) Germany $18.764B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.541B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.079B 77.25
Exact Sciences (EXAS) United States $16.003B 0.00
Horizon Therapeutics Public (HZNP) Ireland $15.953B 37.33
Alnylam Pharmaceuticals (ALNY) United States $14.922B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.942B 101.16
MyoKardia (MYOK) United States $11.820B 0.00
ARGENX SE-ADR (ARGX) Netherlands $11.725B 0.00
QIAGEN (QGEN) Netherlands $11.219B 28.47
Sarepta Therapeutics (SRPT) United States $10.882B 0.00
Guardant Health (GH) United States $10.231B 0.00
Bio-Techne Corp (TECH) United States $10.200B 69.99
Repligen (RGEN) United States $9.321B 147.95
Mirati Therapeutics (MRTX) United States $8.760B 0.00
Ascendis Pharma (ASND) Denmark $8.382B 0.00
Galapagos (GLPG) Belgium $8.316B 30.09
ACADIA Pharmaceuticals (ACAD) United States $7.075B 0.00
Adaptive Biotechnologies (ADPT) United States $6.783B 0.00
Exelixis (EXEL) United States $6.767B 24.61
CRISPR Therapeutics AG (CRSP) Switzerland $6.605B 204.63
Acceleron Pharma (XLRN) United States $6.493B 0.00
Blueprint Medicines (BPMC) United States $5.702B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.529B 0.00
Novavax (NVAX) United States $5.354B 0.00
Emergent Biosolutions (EBS) United States $5.043B 19.98
SWEDISH ORP BIO (BIOVF) Sweden $4.959B 13.55
Arena Pharmaceuticals (ARNA) United States $4.929B 0.00
Amicus Therapeutics (FOLD) United States $4.852B 0.00
NeoGenomics (NEO) United States $4.633B 1398.33
Vir Biotechnology (VIR) United States $4.545B 0.00
Denali Therapeutics (DNLI) United States $4.460B 0.00
China Biologic Products (CBPO) China $4.445B 26.38
Halozyme Therapeutics (HALO) United States $4.225B 0.00
Fate Therapeutics (FATE) United States $4.073B 0.00
Reata Pharmaceuticals (RETA) United States $3.852B 0.00
Insmed (INSM) United States $3.744B 0.00
Twist Bioscience (TWST) United States $3.688B 0.00
Legend Biotech (LEGN) United States $3.581B 0.00
Bluebird Bio (BLUE) United States $3.544B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.537B 0.00
Global Blood Therapeutics (GBT) United States $3.469B 0.00
MorphoSys AG (MOR) Germany $3.346B 43.85
Eidos Therapeutics (EIDX) United States $2.826B 0.00
Alkermes (ALKS) Ireland $2.530B 53.03
PHARMA MAR SA (PHMMF) Spain $2.396B 0.00
I-Mab (IMAB) China $2.350B 0.00
Seres Therapeutics (MCRB) United States $2.276B 0.00
Sorrento Therapeutics (SRNE) United States $2.073B 0.00
Editas Medicine (EDIT) United States $2.001B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.938B 0.00
UniQure (QURE) Netherlands $1.931B 0.00
Amarin (AMRN) Ireland $1.901B 0.00
Zymeworks (ZYME) Canada $1.862B 0.00
Beam Therapeutics (BEAM) United States $1.846B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.817B 20.35
Viela Bio (VIE) United States $1.754B 0.00
Inovio Pharmaceuticals (INO) United States $1.751B 0.00
Intra-Cellular Therapies (ITCI) United States $1.673B 0.00
Revance Therapeutics (RVNC) United States $1.658B 0.00
Sangamo Therapeutics (SGMO) United States $1.578B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.513B 0.00
Intellia Therapeutics (NTLA) United States $1.439B 0.00
Zealand Pharma (ZEAL) Denmark $1.404B 0.00
Ligand Pharmaceuticals (LGND) United States $1.366B 46.16
Northwest Biotherapeutics (NWBO) United States $1.329B 0.00
Mersana Therapeutics (MRSN) United States $1.312B 0.00
Arcus Biosciences (RCUS) United States $1.288B 0.00
Epizyme (EPZM) United States $1.282B 0.00
Mesoblast (MESO) Australia $1.278B 0.00
Coherus BioSciences (CHRS) United States $1.269B 7.40
Zealand Pharma (ZLDPF) Denmark $1.264B 0.00
Alcobra (ARCT) United States $1.223B 0.00
NGM Biopharmaceuticals (NGM) United States $1.193B 0.00
Cytokineticsorporated (CYTK) United States $1.093B 0.00
REGENXBIO (RGNX) United States $1.085B 0.00
Heska (HSKA) United States $1.083B 0.00
Myriad Genetics (MYGN) United States $1.074B 0.00
Retrophin (RTRX) United States $1.069B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.058B 0.00
Genetron Holdings (GTH) China $1.019B 0.00
Castle Biosciences (CSTL) United States $1.003B 0.00
NantKwest (NK) United States $0.975B 0.00
Adverum Biotechnologies (ADVM) United States $0.958B 0.00
Athenex (ATNX) United States $0.955B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.951B 0.00
Compugen (CGEN) Israel $0.950B 0.00
Vericel (VCEL) United States $0.920B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.846B 0.00
Morphic Holding (MORF) United States $0.835B 0.00
Codexis (CDXS) United States $0.827B 0.00
Arvinas (ARVN) United States $0.826B 0.00
Pliant Therapeutics (PLRX) United States $0.805B 0.00
Alector (ALEC) United States $0.778B 0.00
AnaptysBio (ANAB) United States $0.757B 0.00
Cellectis S.A (CLLS) France $0.755B 0.00
Frequency Therapeutics (FREQ) United States $0.751B 0.00
Intrexon (PGEN) United States $0.733B 0.00
Protagonist Therapeutics (PTGX) United States $0.713B 0.00
Pharming Group (PHGUF) Netherlands $0.682B 15.57
Agenus (AGEN) United States $0.670B 0.00
MiMedx (MDXG) United States $0.656B 0.00
Cara Therapeutics (CARA) United States $0.653B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Adaptimmune Therapeutics (ADAP) United Kingdom $0.634B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.631B 0.00
Celldex Therapeutics (CLDX) United States $0.603B 0.00
Kadmon Holdings (KDMN) United States $0.581B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.580B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.570B 4.99
VBI Vaccines (VBIV) United States $0.569B 0.00
Geron (GERN) United States $0.568B 0.00
IVERIC Bio (ISEE) United States $0.534B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.503B 0.00
Cel-Sci (CVM) United States $0.499B 0.00
Albireo Pharma (ALBO) United States $0.495B 0.00
Anika Therapeutics (ANIK) United States $0.492B 21.52
MeiraGTx Holdings (MGTX) United States $0.486B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.486B 0.00
MannKind (MNKD) United States $0.477B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.472B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.468B 0.00
Clovis Oncology (CLVS) United States $0.462B 0.00
Prothena (PRTA) Ireland $0.453B 0.00
UROGEN PHARMA (URGN) United States $0.440B 0.00
Sutro Biopharma (STRO) United States $0.439B 0.00
Amryt Pharma (AMYT) United Kingdom $0.438B 0.00
Kala Pharmaceuticals (KALA) United States $0.433B 0.00
Dynavax Technologies (DVAX) United States $0.430B 0.00
Avid Bioservices (CDMO) United States $0.428B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.424B 0.00
Starpharma Holdings (SPHRY) Australia $0.419B 0.00
Scholar Rock Holding (SRRK) United States $0.410B 0.00
Merus (MRUS) Netherlands $0.380B 0.00
Puma Biotechnology (PBYI) United States $0.378B 0.00
Forte Biosciences (FBRX) United States $0.373B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.367B 0.00
Cue Biopharma (CUE) United States $0.363B 0.00
Cellular Biomedicine (CBMG) United States $0.356B 0.00
ANI Pharmaceuticals (ANIP) United States $0.351B 8.29
Kamada (KMDA) Israel $0.350B 16.72
AC Immune SA (ACIU) Switzerland $0.348B 0.00
Trevena (TRVN) United States $0.342B 0.00
Spero Therapeutics (SPRO) United States $0.342B 0.00
Cardiff Oncology (CRDF) United States $0.340B 0.00
Precision BioSciences (DTIL) United States $0.340B 0.00
Selecta Biosciences (SELB) United States $0.335B 0.00
Athersys (ATHX) United States $0.334B 0.00
IBio (IBIO) United States $0.334B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.331B 0.00
BioDelivery Sciences (BDSI) United States $0.329B 23.29
Aeglea BioTherapeutics (AGLE) United States $0.323B 0.00
Innate Pharma S.A (IPHA) France $0.316B 0.00
Syros Pharmaceuticals (SYRS) United States $0.313B 0.00
CytomX Therapeutics (CTMX) United States $0.307B 0.00
NextCure (NXTC) United States $0.301B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.295B 0.00
ChromaDex (CDXC) United States $0.294B 0.00
WAVE Life Sciences (WVE) Singapore $0.279B 0.00
XOMA (XOMA) United States $0.259B 0.00
PDL BioPharma (PDLI) United States $0.254B 0.00
Affimed (AFMD) Germany $0.245B 0.00
Pluristem Therapeutics (PSTI) Israel $0.243B 0.00
TELA Bio (TELA) United States $0.236B 0.00
Arbutus Biopharma (ABUS) United States $0.229B 0.00
Fortress Biotech (FBIO) United States $0.222B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.216B 0.00
Dyadic (DYAI) United States $0.212B 0.00
HOOKIPA Pharma (HOOK) United States $0.209B 0.00
Verastem (VSTM) United States $0.207B 0.00
Five Prime Therapeutics (FPRX) United States $0.200B 0.00
ADMA Biologics Inc (ADMA) United States $0.190B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Eton Pharmaceuticals (ETON) United States $0.184B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.180B 0.00
CorMedix Inc (CRMD) United States $0.177B 0.00
Liquidia Technologies (LQDA) United States $0.169B 0.00
GENFIT S.A (GNFT) France $0.169B 0.00
Cerecor (CERC) United States $0.169B 0.00
DBV Technologies S.A (DBVT) France $0.168B 0.00
Biofrontera AG (BFRA) Germany $0.166B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.159B 0.00
Kindred Biosciences (KIN) United States $0.158B 0.00
Theratechnologies (THTX) Canada $0.156B 0.00
Nicox SA (NICXF) France $0.149B 0.00
VolitionRX (VNRX) United States $0.146B 0.00
Bellus Health (BLU) Canada $0.145B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.144B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.144B 6.70
Checkpoint Therapeutics (CKPT) United States $0.142B 0.00
Aptinyx (APTX) United States $0.140B 0.00
Applied Genetic Technologies (AGTC) United States $0.137B 0.00
Prometic Life Sciences (LMNL) Canada $0.135B 0.00
Exicure (XCUR) United States $0.134B 0.00
SESEN BIO, INC (SESN) United States $0.130B 0.00
Aytu Bioscience (AYTU) United States $0.128B 0.00
Cidara Therapeutics (CDTX) United States $0.128B 0.00
AquaBounty Technologies (AQB) United States $0.126B 0.00
Catalyst Biosciences (CBIO) United States $0.126B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.125B 0.00
Unum Therapeutics (COGT) United States $0.124B 0.00
Lumos Pharma (LUMO) United States $0.120B 0.00
VTv Therapeutics (VTVT) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.113B 0.00
Celyad SA (CYAD) Belgium $0.112B 0.00
Windtree Therapeutics (WINT) United States $0.111B 0.00
Strongbridge Biopharma (SBBP) United States $0.111B 0.00
Gritstone Oncology (GRTS) United States $0.111B 0.00
Orgenesis (ORGS) United States $0.109B 5.53
Abeona Therapeutics (ABEO) United States $0.107B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.102B 0.00
Antibe Therapeutics (ATBPF) Canada $0.099B 0.00
Oncobiologics (OTLK) United States $0.097B 0.00
AIT Therapeutics (XAIR) United States $0.096B 0.00
Palatin Technologies (PTN) United States $0.089B 0.00
Cyclerion Therapeutics (CYCN) United States $0.088B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.086B 0.00
Ecology Coatings (ABVC) United States $0.086B 0.00
Idera Pharmaceuticals (IDRA) United States $0.083B 0.00
DiaMedica Therapeutics (DMAC) United States $0.080B 0.00
ARAVIVE, INC (ARAV) United States $0.079B 0.00
Evogene (EVGN) Israel $0.075B 0.00
Bionano Genomics (BNGO) United States $0.075B 0.00
Stealth BioTherapeutics (MITO) United States $0.075B 72.00
Prima BioMed (IMMP) Australia $0.068B 0.00
Adocia (ADOCY) France $0.067B 0.00
Synlogic (SYBX) United States $0.066B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Organovo Holdings (ONVO) United States $0.064B 0.00
Appili Therapeutics (APLIF) Canada $0.064B 0.00
AmpliPhi Biosciences (ARMP) United States $0.062B 0.00
Clearside Biomedical (CLSD) United States $0.061B 0.00
Curis (CRIS) United States $0.060B 0.00
Edesa Biotech (EDSA) Canada $0.060B 0.00
TRACON Pharmaceuticals (TCON) United States $0.057B 0.00
Proteostasis Therapeutics (PTI) United States $0.056B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.056B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.055B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.054B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.052B 0.00
Soligenix (SNGX) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Cocrystal Pharma (COCP) United States $0.045B 0.00
Genetic Technologies (GENE) Australia $0.045B 0.00
Happiness Biotech Group (HAPP) China $0.044B 0.00
Acorda Therapeutics (ACOR) United States $0.043B 0.00
Novogen (KZIA) Australia $0.041B 0.00
IMMURON (IMRN) Australia $0.041B 0.00
CollPlant Holdings (CLGN) Israel $0.040B 0.00
Vaccinex (VCNX) United States $0.040B 0.00
AnPac Bio-Medical Science (ANPC) China $0.039B 0.00
Pulmatrix (PULM) United States $0.038B 0.00
Chanticleer Holdings (SONN) United States $0.037B 0.00
Apricus Biosciences (SEEL) United States $0.034B 0.00
Cleveland BioLabs (CBLI) United States $0.033B 0.00
ATyr Pharma (LIFE) United States $0.033B 0.00
OvaScience (MLND) United States $0.031B 0.00
Advaxis (ADXS) United States $0.029B 0.00
Signal Genetics (MGEN) United States $0.028B 0.00
BioCardia (BCDA) United States $0.026B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Prana Biotechnology (ATHE) Australia $0.023B 0.00
Celsion (CLSN) United States $0.023B 0.00
Aptevo Therapeutics (APVO) United States $0.023B 0.00
Alimera Sciences (ALIM) United States $0.022B 0.00
Spherix (AIKI) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.016B 0.00
Cesca Therapeutics (THMO) United States $0.015B 0.00
Titan Pharmaceuticals (TTNP) United States $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
BioPharmX (TMBR) United States $0.012B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
GeoVax Labs (GOVX) United States $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00